Caroline Moore
#43,475
Most Influential Person Now
Professor of Urology at University College London
Caroline Moore 's AcademicInfluence.com Rankings
Caroline Moore medical Degrees
Medical
#522
World Rank
#708
Historical Rank
Urology
#13
World Rank
#14
Historical Rank
Download Badge
Medical
Why Is Caroline Moore Influential?
(Suggest an Edit or Addition)According to Wikipedia, Caroline M. Moore is the first woman to be made a professor of urology in the United Kingdom. She works in the diagnosis and treatment of prostate cancer at University College London. Her research on evaluating photodynamic therapy for prostate cancer, became the subject of her MD, which was completed in 2007, and led to the first completed randomised trial comparing focal treatment for prostate cancer with active surveillance.
Caroline Moore 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis (2018) (1661)
- Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. (2013) (564)
- Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. (2013) (413)
- Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. (2015) (313)
- Photodynamic therapy for prostate cancer—a review of current status and future promise (2009) (281)
- Weakly-supervised convolutional neural networks for multimodal image registration (2018) (272)
- Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus Meeting (2015) (226)
- Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. (2013) (195)
- A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer (2018) (192)
- Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. (2017) (185)
- Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. (2013) (177)
- Multiparametric MRI for prostate cancer diagnosis: current status and future directions (2019) (161)
- Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer (2006) (160)
- TOOKAD® Soluble vascular‐targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer (2013) (139)
- Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis. (2019) (124)
- Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer (2012) (120)
- Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis. (2020) (117)
- Label-driven weakly-supervised learning for multimodal deformarle image registration (2017) (106)
- Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. (2009) (100)
- The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy (2017) (97)
- Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial. (2020) (97)
- National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection – recommendations from a UK consensus meeting (2018) (96)
- Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. (2012) (88)
- Detection, localisation and characterisation of prostate cancer by Prostate HistoScanning™ (2012) (85)
- Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11‐vascular‐targeted photodynamic (VTP) therapy (2015) (85)
- Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy (2010) (84)
- Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary localized prostate cancer (2019) (82)
- The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation. (2012) (80)
- Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study☆ (2020) (68)
- “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now (2020) (64)
- A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance (2015) (64)
- Adversarial Deformation Regularization for Training Image Registration Neural Networks (2018) (63)
- Is magnetic resonance imaging‐targeted biopsy a useful addition to systematic confirmatory biopsy in men on active surveillance for low‐risk prostate cancer? A systematic review and meta‐analysis (2018) (60)
- Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review. (2020) (60)
- Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach (2017) (59)
- Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort. (2016) (58)
- MRI-targeted prostate biopsy: a review of technique and results (2013) (58)
- Expert consensus document: Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure (2017) (57)
- Prostate cancer (2021) (56)
- Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study (2018) (55)
- Photodynamic therapy for focal ablation of the prostate (2010) (54)
- The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification (2019) (54)
- A critical comparison of techniques for MRI-targeted biopsy of the prostate (2017) (54)
- The role of MRI in active surveillance of prostate cancer (2013) (52)
- Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. (2019) (52)
- The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. (2014) (52)
- VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient (2019) (45)
- PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy Naive Men with Suspected Prostate Cancer: A Narrative Review. (2020) (45)
- Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial (2018) (43)
- Inter-site Variability in Prostate Segmentation Accuracy Using Deep Learning (2018) (42)
- Automatic segmentation of prostate MRI using convolutional neural networks: Investigating the impact of network architecture on the accuracy of volume measurement and MRI-ultrasound registration (2019) (41)
- Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. (2021) (41)
- MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years (2018) (40)
- Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis (2014) (38)
- INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer (2016) (37)
- Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation (2015) (36)
- Does photodynamic therapy have the necessary attributes to become a future treatment for organ‐confined prostate cancer? (2005) (36)
- MRI in active surveillance: a critical review (2018) (36)
- Conceptual basis for focal therapy in prostate cancer. (2010) (35)
- Focal salvage high‐intensity focused ultrasound in radiorecurrent prostate cancer (2017) (34)
- Translational Andrology and Urology (2017) (34)
- Population-based prediction of subject-specific prostate deformation for MR-to-ultrasound image registration (2015) (34)
- Photodynamic therapy for prostate cancer—an emerging approach for organ‐confined disease (2011) (33)
- Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes (2017) (32)
- Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model (2009) (32)
- Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging (2018) (31)
- The Evolution of MRI of the Prostate: The Past, the Present, and the Future. (2019) (30)
- Accuracy of HistoScanning™ for the prediction of a negative surgical margin in patients undergoing radical prostatectomy (2013) (30)
- Can MRI replace serial biopsies in men on active surveillance for prostate cancer? (2014) (29)
- Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy. (2020) (29)
- Integration of spatial information in convolutional neural networks for automatic segmentation of intraoperative transrectal ultrasound images (2018) (26)
- Multiparametric Magnetic Resonance Imaging in the Management and Diagnosis of Prostate Cancer: Current Applications and Strategies (2014) (26)
- Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort (2020) (26)
- Patient‐reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments (2017) (25)
- Focal therapy in prostate cancer: determinants of success and failure. (2010) (24)
- MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial (2017) (24)
- Role of MRI in planning radical prostatectomy: what is the added value? (2019) (24)
- MAPPED study design: a 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging. (2013) (22)
- MRI-Targeted Biopsy for Prostate-Cancer Diagnosis. (2018) (22)
- Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement (2019) (22)
- Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate (2015) (22)
- Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists (2021) (21)
- Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance. (2019) (21)
- The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED—A Randomized, Placebo Controlled, Double‐Blind Clinical Trial (2017) (21)
- Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study (2020) (20)
- Automatic slice segmentation of intraoperative transrectal ultrasound images using convolutional neural networks (2018) (19)
- Light penetration in the human prostate: a whole prostate clinical study at 763 nm. (2011) (19)
- A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review. (2017) (18)
- Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound (2019) (18)
- Evaluation of functional outcomes after a second focal high‐intensity focused ultrasonography (HIFU) procedure in men with primary localized, non‐metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry (2020) (17)
- A Modified Newcastle-Ottawa Scale for Assessment of Study Quality in Genetic Urological Research. (2020) (17)
- Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK (2018) (16)
- Reorganising specialist cancer surgery for the twenty-first century: a mixed methods evaluation (RESPECT-21) (2016) (16)
- Development and Phantom Validation of a 3-D-Ultrasound-Guided System for Targeting MRI-Visible Lesions During Transrectal Prostate Biopsy (2017) (16)
- Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models (2017) (16)
- A cohort study of 30 day mortality after NON-EMERGENCY surgery in a COVID-19 cold site (2020) (16)
- Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals (2018) (15)
- Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial (2021) (15)
- A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol (2017) (15)
- The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature. (2020) (15)
- A Dedicated Prostate MRI Teaching Course Improves the Ability of the Urologist to Interpret Clinically Significant Prostate Cancer on Multiparametric MRI. (2019) (14)
- Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study (2019) (14)
- Intraoperative Organ Motion Models with an Ensemble of Conditional Generative Adversarial Networks (2017) (14)
- PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure (2016) (14)
- Focal HIFU therapy for anterior compared to posterior prostate cancer lesions (2020) (14)
- The "Is mpMRI Enough" or IMRIE Study: A Multicentre Evaluation of Prebiopsy Multiparametric Magnetic Resonance Imaging Compared with Biopsy. (2020) (13)
- Magnetic resonance imaging in active surveillance—a modern approach (2018) (13)
- PSA Criteria to Diagnose Failure of Cancer Control following Focal Therapy for Non-metastatic Prostate Cancer Using High Intensity Focused Ultrasound. (2020) (12)
- Prostate cancer detection using quantitative T2 and T2‐weighted imaging: The effects of 5‐alpha‐reductase inhibitors in men on active surveillance (2018) (12)
- The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series. (2020) (12)
- When no treatment is the best treatment: Active surveillance strategies for low risk prostate cancers. (2017) (12)
- Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score (2021) (12)
- Cancer Control Outcomes Following Focal Therapy Using High-intensity Focused Ultrasound in 1379 Men with Nonmetastatic Prostate Cancer: A Multi-institute 15-year Experience. (2022) (12)
- 936 TOOKAD ® SOLUBLE (PADELIPORFIN) SECOND GENERATION VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR PROSTATE CANCER: SAFETY AND FEASIBILITY (2010) (12)
- The natural history of prostate cancer on MRI: lessons from an active surveillance cohort (2018) (12)
- Update on multiparametric prostate MRI during active surveillance: current and future trends and role of the PRECISE recommendations. (2020) (12)
- 86 RESULTS OF TOOKAD® SOLUBLE VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR LOW RISK LOCALIZED PROSTATE CANCER (PCM201/PCM203) (2011) (12)
- Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program. (2019) (12)
- Role of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancer (2014) (11)
- Application of the PRECISION Trial Biopsy Strategy to a Contemporary MRI-Targeted Biopsy Cohort: How Many Clinically Significant Prostate Cancers are Missed? (2020) (11)
- Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses. (2018) (11)
- Focal therapy for prostate cancer: fact or fiction? (2010) (11)
- Role of MRI in low-risk prostate cancer: finding the wolf in sheep's clothing or the sheep in wolf's clothing? (2017) (11)
- Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management (2018) (11)
- Focal therapy for prostate cancer: a potential strategy to address the problem of overtreatment. (2010) (10)
- Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning (2018) (10)
- Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches (2018) (10)
- Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI‐characterized prostates (2018) (9)
- Inflammatory responses to parasites (1987) (9)
- Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data (2021) (9)
- Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome. (2019) (9)
- DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations. (2019) (9)
- Magnetic Resonance Imaging Should Be Used in the Active Surveillance of Patients with Localised Prostate Cancer. (2019) (9)
- Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS (2019) (9)
- Implementing major system change in specialist cancer surgery: The role of provider networks (2020) (9)
- 1788 RESULTS OF TOOKAD® SOLUBLE VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR LOW RISK LOCALIZED PROSTATE CANCER (PCM203) (2011) (9)
- ‘ National Implementation of multi-parametric MRI for prostate cancer detection – Recommendations from a UK consensus meeting ’ (2018) (8)
- Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program (2021) (8)
- Technical Note: Error metrics for estimating the accuracy of needle/instrument placement during transperineal magnetic resonance/ultrasound‐guided prostate interventions (2018) (8)
- The role of additional standard biopsy in the MRI-targeted biopsy era. (2020) (7)
- Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control (2021) (7)
- 1096 The natural history of untreated prostate MRI lesions in an active surveillance prostate cancer population – 260 patient-years (2012) (7)
- Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial (2021) (7)
- Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISE. (2020) (6)
- Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models (2021) (6)
- Integrating MRI for the diagnosis of prostate cancer (2016) (6)
- Added value of diffusion‐weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial (2019) (6)
- THE EFFECTS OF THE TIME PERIOD BETWEEN BIOPSY AND DIFFUSION‐WEIGHTED MAGNETIC RESONANCE IMAGING ON CANCER STAGING IN LOCALIZED PROSTATE CANCER (2009) (6)
- Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium (2022) (6)
- Prostate evaluation for clinically important disease: Sampling using image-guidance or not? (The PRECISION study, NCT02380027) (2018) (6)
- VASCULAR-TARGETED PHOTODYNAMIC THERAPY IN ORGAN CONFINED PROSTATE CANCER -REPORT OF A NOVEL PHOTOSENSITISER (2006) (5)
- Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging. (2021) (5)
- MP53-03 TRANSPERINEAL MRI VISUALLY-TARGETED PROSTATE BIOPSIES COMPARED TO TEMPLATE MAPPING BIOPSY IN 534 MEN REQUIRING FURTHER RISK STRATIFICATION (2016) (5)
- "Don't Let the Perfect Be the Enemy of the Good": Time to Embrace Magnetic Resonance Imaging Before First Prostate Biopsy. (2018) (5)
- MRI in early detection of prostate cancer. (2019) (5)
- Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study. (2022) (5)
- An exploratory study of dose escalation versus standard focal High Intensity Focused Ultrasound for treating non-metastatic prostate cancer. (2020) (5)
- Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship (2022) (5)
- Photodynamic therapy for primary prostate cancer - A pilot study using MTHPC (2004) (5)
- Establishing a global quality of care benchmark report (2021) (5)
- Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study (2022) (5)
- Role of MRI for the detection of prostate cancer (2021) (4)
- Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function—a retrospective study in low-risk prostate cancer patients (2021) (4)
- Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis (2021) (4)
- 133 A NEGATIVE MULTI-PARAMETRIC MRI CAN RULE OUT UP TO 97% OF CLINICALLY SIGNIFICANT PROSTATE CANCER (2011) (4)
- The Importance of Being PRECISE in Prostate Magnetic Resonance Imaging and Active Surveillance. (2021) (4)
- ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI (2021) (4)
- Tookad soluble (WST-11) second generation vascular targeted photodynamic therapy (VTP) for prostate cancer: Safety and feasibility (2011) (4)
- Focal therapy for prostate cancer. Alternative treatment. (2014) (4)
- Can Negative Prostate Magnetic Resonance Imaging Give Us the Reassurance We Need To Avoid Standard Biopsy? An Evidence-based Practical Approach. (2018) (4)
- What to expect from a non-suspicious prostate MRI? A review. (2020) (4)
- MP18-08 FOCAL HIFU FOR TREATMENT OF LOCALISED PROSTATE CANCER: A MULTI-CENTRE REGISTRY EXPERIENCE (2016) (4)
- [Focal therapy for prostate cancer: German version]. (2015) (4)
- Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer? (2021) (3)
- 275 The prevalence of depression and anxiety in men undergoing active surveillance for prostate cancer (2013) (3)
- Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype (2020) (3)
- There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis (2022) (3)
- Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. (2023) (3)
- Outcomes of the RAFT trial: robotic surgery after focal therapy (2021) (3)
- Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease? (2021) (3)
- Prostate-specific membrane antigen PET-CT before radical treatment (2020) (3)
- MP67-11 PROSTATE IMAGING (MULTI-PARAMETRIC MRI AND PROSTATE HISTOSCANNING™) COMPARED TO TRANSPERINEAL ULTRASOUND GUIDED BIOPSY FOR SIGNIFICANT PROSTATE CANCER RISK EVALUATION- THE PICTURE STUDY (2014) (3)
- A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance (2021) (3)
- The Evolution of Active Surveillance for Prostate Cancer. (2015) (3)
- Magnetic Resonance Imaging–guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies (2022) (3)
- Medium term oncological outcomes in a large cohort of men treated with either focal- or hemi-ablation with HIFU for primary localized prostate cancer (2019) (2)
- Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship (2022) (2)
- Negative predictive value of multi-parametric MRI in detection of clinically significant prostate cancer: A systematic review and meta-analysis (2019) (2)
- 967 ULTRASOUND SPECTRAL INTERROGATION OF HISTOLOGICAL GRADE IN PROSTATE CANCER USING PROSTATE HISTOSCANNING (2011) (2)
- Dynamic contrast-enhanced magnetic resonance imaging after vascular targeted photodynamic therapy with tookad in the primary treatment of prostate cancer (2007) (2)
- The role of multiparametric MRI in men with negative biopsy and elevated PSA - can it rule out clinically significant disease? (2012) (2)
- Novel methods of treating early prostate cancer: cryotherapy and high‐intensity focused ultrasound (2010) (2)
- Focal therapy for prostate cancer. Rationale, indications and selection. (2014) (2)
- Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; Results from the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry. (2020) (2)
- Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study (2021) (2)
- Mixed acinar and macrocystic ductal prostatic adenocarcinoma. (2021) (2)
- Dynamic contrast-enhanced magnetic resonance imaging after vascular-targeted photodynamic therapy (VTP) with Tookad (Padoporfin) in primary prostate cancer (2008) (2)
- Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative (2022) (2)
- Will the attributes of multiparametric MRI permit the creation of a new approach to therapy? (2015) (2)
- Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy. (2022) (2)
- Reply from authors re: Behfar ehdaie, shahrokh F. shariat. magnetic resonance imaging-targeted prostate biopsy: Back to the future. Eur urol 2013;63:141-2: What will it cost to target clinically relevant prostate cancer? (2013) (2)
- Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database (2021) (2)
- Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study (2021) (2)
- PD17-03 PROSTATE CANCER PATIENTS THAT OPTED FOR ACTIVE SURVEILLANCE WHILE HAVING A SUSPICIOUS MRI ARE AT INCREASED RISK OF NEEDING TREATMENT. RESULTS OF THE MOVEMBER FOUNDATION’S GLOBAL ACTION PLAN PROSTATE CANCER ACTIVE SURVEILLANCE (GAP3) CONSORTIUM (2021) (2)
- MP-16.13: Vascular-Targeted Photodynamic Therapy Using WST11 in Patients with Localized Prostate Cancer (2009) (2)
- The ability of MRI guided biopsy to detect clinically significant prostate cancer: a systematic review. (2012) (2)
- SURGICAL MANAGEMENT AFTER ACTIVE SURVEILLANCE FOR LOW‐RISK PROSTATE CANCER: PATHOLOGICAL OUTCOMES COMPARED WITH MEN UNDERGOING IMMEDIATE TREATMENT (2011) (2)
- “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now (2020) (2)
- A feasibility study of a psycho‐educational support intervention for men with prostate cancer on active surveillance (2020) (2)
- The natural history of untreated prostate MRI lesions in an active surveillance prostate cancer population – 260 patient-years (2012) (2)
- MP78-12 ROBOTIC ASSISTED RADICAL PROSTATECTOMY AFTER FOCAL THERAPY: ONCOLOGICAL AND FUNCTIONAL OUTCOMES (2019) (2)
- Light Density Index (LDI) is a Predictor of MRI and Biopsy Outcome for WST-11 (Tookad Soluble™) Mediated Vascular Targeted Photodynamic Therapy (VTP) in Focal Treatment of Localised Prostate Cancer (2010) (2)
- Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative (2022) (2)
- 2049 MAGNETIC RESONANCE IMAGE-GUIDED PROSTATE BIOPSY VERSUS TRANSPERINEAL TEMPLATE PROSTATE BIOPSY IN THE DIAGNOSIS OF CLINICALLY SIGNIFICANT PROSTATE CANCER (2012) (2)
- The Role of MRI in Active Surveillance (2012) (2)
- Late toxicity described using patient reported outcomes measures (PROMS) in men treated with salvage radiation following primary high intensity focal ultrasound (HIFU) for localized prostate cancer. (2019) (2)
- THE SMARTTARGET BIOPSY TRIAL: A PROSPECTIVE PAIRED BLINDED TRIAL WITH RANDOMISATION TO COMPARE VISUAL‐ESTIMATION AND IMAGE‐FUSION TARGETED PROSTATE BIOPSIES: MP33‐20 (2017) (2)
- MP78-14 SITE OF DISEASE RECURRENCE FOLLOWING PROSTATE FOCAL THERAPY PREDICTS ONCOLOGICAL OUTCOME AFTER SALVAGE ROBOTIC ASSISTED RADICAL PROSTATECTOMY (2019) (2)
- MRI-Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review. (2021) (1)
- MRI as a follow up tool in active surveillance – results from an MRI-defined active surveillance cohort (387 men, median 5 year follow up) (2017) (1)
- 1352 RADIOLOGICAL PROGRESSION IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE (2013) (1)
- A CLINICAL EVALUATION OF THE OPTICAL CHARACTERISTICS OF THE PROSTATE IN MEN WITH PROSTATE CANCER (2006) (1)
- Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis (2022) (1)
- Prostate High-Intensity Focused Ultrasound (2010) (1)
- Focal Photodynamic Therapy (2015) (1)
- MRI and targeted biopsies compared to transperineal mapping biopsies for targeted ablation in recurrent prostate cancer after radiotherapy: Primary outcomes of the FORECAST trial. (2021) (1)
- The effect of dutasteride on MRI-defined prostate cancer lesions: MAPPED (Magnetic resonance imaging in Primary Prostate Cancer after Exposure to Dutasteride) - a randomized placebo-controlled, double-blind clinical trial (2017) (1)
- Geographic Variability, Time Trends and Association of Preoperative MRI with Surgical Outcomes for Elderly US Men with Prostate Cancer: A SEER-Medicare Analysis. (2022) (1)
- The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer (2021) (1)
- Visible disease at baseline accelerates time to exit from MRI-based active surveillance (2019) (1)
- An important step towards smarter screening for prostate cancer. (2021) (1)
- Focal HIFU: Higher recurrence rate in treatment of anterior compared to posterior lesions in prostate cancer (2018) (1)
- Development of Technologic Solutions to Address Complex Local Requirements of an International Prostate Cancer Clinical Quality Registry. (2019) (1)
- Late Toxicity and Patient Reported Outcomes in Patients Treated With Salvage Radiation Following Primary High Intensity Focal Ultrasound for Localized Prostate Cancer (2017) (1)
- A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer (2022) (1)
- Morphological Change Forecasting For Prostate Glands Using Feature-Based Registration And Kernel Density Extrapolation (2021) (1)
- PD34-07 PSA FAILS TO PREDICT TREATMENT FAILURE IN FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND THERAPY IN PROSTATE CANCER (2018) (1)
- Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database (2022) (1)
- Mycobacterial immunotherapy for prostate cancer: where can we go from here? (2020) (1)
- The intracellular component of VERDICT ( Vascular , Extracellular , and Restricted Di ff usion for Cytometry in Tumors ) MRI distinguishes Gleason 4 pattern better than Apparent Di ff usion Coe ffi cient (2017) (1)
- 844 PERFORMANCES OF TEMPLATE PROSTATE MAPPING (TPM) VERSUS TRANSRECTAL ULTRASOUND GUIDED (TRUS) BIOPSIES: AN ORIGINAL COMPUTER SIMULATION ON CYSTOPROSTECTOMY SPECIMENS (2011) (1)
- DUTASTERIDE AND ACTIVE SURVEILLANCE IN PROSTATE CANCER: ARE VISIBLE LESIONS LESS CONSPICUOUS AT MAGNETIC RESONANCE IMAGING? A PILOT RANDOMIZED CONTROLLED TRIAL: PD55‐01 (2017) (1)
- Debate: A uniform issue. (2013) (1)
- Active Surveillance for Prostate Cancer: Will Magnetic Resonance Imaging Help Us Address the Current Controversies in Traditional Surveillance Approaches? (2022) (1)
- Legal Basis—EU (2007) (1)
- Inclusion: An Annotated Bibliography. (1994) (0)
- THE PROBLEM OF OVERTREATMENT (2010) (0)
- Validation of the needle targeting accuracy of a MRI/TRUS- image-guided system for transperineal prostate cancer biopsy (2015) (0)
- PD60-11 DISTINCT PROTEIN EXPRESSION PATTERNS FOR COMMON BIOMARKERS IN MALIGNANT AND ADJACENT BENIGN PROSTATE TISSUE: AN IMMUNOHISTOCHEMICAL STUDY ON NEEDLE BIOPSY MICROARRAYS DERIVED FROM AN IMAGING-BASED PATIENT COHORT (2018) (0)
- Magnetic resonance imaging and prostate cancer: Perspectives from the UK, Europe and USA. (2019) (0)
- MP30-11 PREDICTORS OF POOR FUNCTIONAL OUTCOMES AFTER FOCAL HIGH INTENSITY FOCUSSED ULTRASOUND (HIFU) (2018) (0)
- 893 TRIFECTA OUTCOMES AFTER WHOLE-GLAND HIGH INTENSITY FOCUSED ULTRASOUND FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A REGISTRY-BASED ANALYSIS (2011) (0)
- Addition of Anterior Cores in Transrectal Prostate Biopsies Cannot Replace Performance of Template-Mapping Biopsies in Detection of Prostate Cancer: A Simulation on Cystoprostatectomy Specimens (2010) (0)
- Minimally invasive therapies in prostate and renal cancer (2010) (0)
- Histo-MRI map study protocol: a prospective cohort study mapping MRI to histology for biomarker validation and prediction of prostate cancer (2022) (0)
- A randomized controlled trial to investigate magnetic resonance imaging-targeted biopsy as an alternative diagnostic strategy to transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. (2015) (0)
- A historical evaluation of the changes in prostate cancer diagnosis over eight decades (2011) (0)
- 6th International Workshop on Osteoarthritis Imaging combined with the OARSI OA Biomarkers Workshop III-Imaging Biomarker Validation and Qualification (2012) (0)
- The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy (2017) (0)
- Is focal ablation as effective as hemi-ablation? analysis of treatment patterns over 12 years from a high volume centre for focal therapy (2020) (0)
- Focal ablative salvage therapy for radio-recurrent prostate cancer: 6 year oncological and safety outcomes (2021) (0)
- Distinct immunohistochemical findings for common biomarkers in malignant and adjacent benign prostate: A study on needle biopsy microarrays derived from mpMRI-characterized tissue (2018) (0)
- MRI in men on active surveillance for prostate cancer: The PRECISE recommendations (2018) (0)
- Protocol for a MULTI-centre feasibility study to assess the use of 99mTc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study) (2023) (0)
- INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer (2016) (0)
- Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes? (2020) (0)
- A TRAINING COURSE FOR THE UROLOGIST IMPROVES THEIR ABILITY TO INTERPRET CLINICALLY SIGNIFICANT PROSTATE CANCER ON MULTIPARAMETRIC MRI: MP51‐12 (2017) (0)
- 1251 THE START CONSORTIUM RECOMMENDATIONS FOR THE REPORTING OF MRI–TARGETED PROSTATE BIOPSIES (2013) (0)
- Can PROMs improve racial equity in outcomes after prostatectomy? (2022) (0)
- MP-13.03 Does Repeat Focal Ablation using High Intensity Focused Ultrasound (Sonablate 500) Compromise Morbidity or Genito-Urinary Functional Outcome in Men with Localized Prostate Cancer? (2011) (0)
- Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing (2022) (0)
- Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing (2022) (0)
- Combining mpMRI sequences for the diagnosis of prostate cancer – the value of adding diffusion and contrast enhancement to T2W on 3Tesla: Outcomes from the PICTURE trial (2016) (0)
- Sexual dysfunction and prostate cancer therapy (2016) (0)
- MP46-05 IRREVERSIBLE ELECTROPORATION OF THE PROSTATE: PREDICTING THE LIKELIHOOD OF AVOIDING RADICAL THERAPY IN A MODERATE TO HIGH RISK COHORT OF MEN (2021) (0)
- MP55-01 CANCER CONTROL OUTCOMES FOLLOWING FOCAL THERAPY USING HIFU IN 1,379 MEN WITH NON-METASTATIC PROSTATE CANCER: A MULTI-INSTITUTE 15-YEAR EXPERIENCE (2022) (0)
- MP78-10 A COMPARISON OF CANCER CONTROL OUTCOMES AT 5 YEARS OF FOCAL THERAPY (USING HIFU & CRYOTHERAPY) TO RADICAL PROSTATECTOMY FOR CLINICALLY SIGNIFICANT NON-METASTATIC PROSTATE CANCER: PROPENSITY SCORE-MATCHED ANALYSIS (2019) (0)
- PD50-02 NATURAL HISTORY OF PROSTATE CANCER ON ACTIVE SURVEILLANCE: STRATIFICATION BY MRI USING THE PRECISE RECOMMENDATIONS IN A UK COHORT OVER 11 YEARS (2019) (0)
- Seminar: Revisiting the value of PSA-based prostate cancer screening Essay No 5: Should men undergo MRI before prostate biopsy? (Pro). (2022) (0)
- A new quality control scoring system for multiparametric MRI of the prostate from the PRECISION trial (2020) (0)
- MP26-07 WHICH PROSTATE CANCERS ARE UNDETECTED BY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN MEN WITH PRIOR PROSTATE BIOPSY? AN ANALYSIS FROM THE PICTURE STUDY (2021) (0)
- MAPPED: Magnetic resonance imaging in Primary Prostate cancer after Exposure to Dutasteride: Reduction in tumour volume at 6 months in men on active surveillance for prostate cancer (2014) (0)
- A Systematic Review and Meta-Analysis of Patient Race, Ethnicity, Socioeconomic Status and Educational Attainment in Prostate Cancer Treatment Randomised Trials – Is the Evidence Base Applicable to the General Patient Population? (2022) (0)
- USING MP‐MRI GUIDED PROSTATE NEEDLE BIOPSY SAMPLES TO IMPROVE PROSTATE CANCER DIAGNOSIS.: PD65‐10 (2017) (0)
- 820 The importance of a visible lesion in imaging based active surveillance for prostate cancer (2015) (0)
- Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol (2023) (0)
- 'Cognitive' MRI-guided TRUS biopsy targeting - does it require specialist radiological expertise? (2012) (0)
- MP24-19 NEGATIVE PREDICTIVE VALUE OF MULTI-PARAMETRIC MRI IN DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS (2019) (0)
- 227 DEPRESSION AND ANXIETY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2013) (0)
- 1466 COULD USE OF MRI IN MEN REFERRED FOR RISK OF PROSTATE CANCER RESULT IN A REDUCTION OF BIOPSY RELATED MORBIDITY WHEN COMPARED TO THE ERSPC AND PCPT RISK CALCULATORS FOR DECISION TO BIOPSY (2013) (0)
- ReIMAGINE Prostate Cancer Risk: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood, urine and imaging for biomarker analyses (2023) (0)
- Abstract B38: Photochemical internalisation for the local delivery of chemotherapy in prostate cancer (2015) (0)
- An opportunity for men with positive prostate mpMRI studies to safely avoid biopsy – Results from the INNOVATE Study (2021) (0)
- The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses. (2022) (0)
- MRI in prostate cancer diagnosis: do we need to add standard sampling? A review of the last 5 years (2018) (0)
- Baseline characteristics in an MRI-based active surveillance cohort: Association with clinical and histological outcomes (2018) (0)
- PSA density and clinical outcome in MRI-based active surveillance for prostate cancer: A joint longitudinal-survival analysis (2021) (0)
- A MULTIVARIATE LOGISTIC REGRESSION INVESTIGATING WHICH FACTORS INFLUENCE DETECTION OF CLINICALLY SIGNIFICANT CANCER BY MRI‐TARGETED PROSTATE BIOPSY: PD43‐06 (2017) (0)
- MP55-06 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: 6 YEAR ONCOLOGICAL AND SAFETY OUTCOMES (2022) (0)
- The natural history of prostate cancer on MRI: lessons from an active surveillance cohort (2018) (0)
- Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals (2018) (0)
- 324 Is PSA density a useful biomarker in the age of frequent imaging for prostate cancer (2015) (0)
- Can TRUS Power Doppler Predict the Preservation of Erectile Function in HIFU Treatment of Localised Prostate Cancer? — A Preliminary Study (2006) (0)
- Can MRI replace biopsy in men on surveillance (2018) (0)
- Improving the diagnosis and treatment of high‐risk localised or locally advanced prostate cancer (2015) (0)
- 6. Photodynamic Therapy (2011) (0)
- Follow-Up of Men With PI-RADS 4 or 5 Abnormality on Prostate MRI and Non-Malignant Pathologic Findings on Initial Targeted Prostate Biopsy. (2020) (0)
- Differentiating False Positive Lesions from Clinically Significant Cancer and Normal Prostate Tissue Using VERDICT MRI and Other Diffusion Models (2022) (0)
- Global variations in treatment decisions among men with localized prostate cancer: Patterns of care in 15,718 men from 9 countries (2020) (0)
- MP-03.05 Can Pre-Biopsy Multiparametric MRI Be Used to Detect Significant Prostate Cancer? (2011) (0)
- 321 European multi-centre study to assess the aggressiveness of prostate adenocarcinoma in newly-diagnosed patients using a cell-cycle gene expression assay (Prolaris™) in biopsy specimens (EMPATHY-P Study) (2015) (0)
- Knowledge and insights from a maturing international clinical quality registry (2022) (0)
- Comparison of biparametric and multiparametric magnetic resonance imaging for prostate cancer detection: an 8-month update on the PRIME Study (NCT04571840) (2023) (0)
- 498 The UCL PICTURE trial: A prospective cohort validating study evaluating the accuracy of multi-parametric MRI and prostate HistoScanning compared to transperineal template mapping biopsies in patients requiring risk stratification after prior transrectal prostate biopsy (2016) (0)
- Robotic assisted radical prostatectomy after focal therapy: Oncological and functional outcomes (2019) (0)
- The Global Reading Room: MRI-Targeted Prostate Biopsy After Proctocolectomy. (2022) (0)
- 2213 RESULTS OF MRI TARGETED, VISUALLY REGISTERED, TRANS-RECTAL ULTRASOUND GUIDED PROSTATE BIOPSY (2013) (0)
- Natural history of prostate cancer during active surveillance on MRI using the PRECISE criteria: A multicentre study (2023) (0)
- Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype (2020) (0)
- Title: Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity matched study (2021) (0)
- P042 Late toxicity in patients treated with salvage radical radiotherapy following primary High-Intensity Focal Ultrasound (HIFU) for localized prostate cancer (2014) (0)
- ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement (2021) (0)
- MP24-18 SYSTEMATIC REVIEW AND META-ANALYSIS OF SIGNIFICANT CANCER DETECTION BY MRI-TARGETED BIOPSY COMPARED TO SYSTEMATIC BIOPSY (2019) (0)
- MP73-08 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: A 10 YEAR EXPERIENCE OF ONCOLOGICAL AND SAFETY OUTCOMES IN 276 PATIENTS (2023) (0)
- PD22-01 THE GLIMPSE STUDY: GLOBAL VARIATION IN THE QUALITY OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE FROM THE PRIME TRIAL (2023) (0)
- 951 The PICTURE Study – prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation (2014) (0)
- Negative predictive value of multi-parametric MRI in detection of clinically significant prostate cancer in the PI-RADS era: a systematic review and meta-analysis (2020) (0)
- Oncological outcomes of 356 patients undergoing salvage focal ablative HIFU or cryotherapy following radiation failure. (2020) (0)
- Ultra-fast biparametric MRI for prostate cancer detection (2021) (0)
- Natural history of prostate cancer on active surveillance: Stratification by MRI using the PRECISE recommendations in a UK cohort over 11 years (2019) (0)
- Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry. (2023) (0)
- Reducing biopsies and mris in the diagnostic pathway of prostate cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION trial data (2021) (0)
- Chronic Baseline Prostate Inflammation is Associated with Lower Tumor Grade in Men with Prostate Cancer on Repeat Biopsy: Results from the REDUCE Study. (2020) (0)
- MP19-19 PRIORITIZED RESEARCH QUESTIONS ON THE USE OF ACTIVE SURVEILLANCE FOR THE MANAGEMENT OF PROSTATE CANCER: RESULTS FROM PCASRI CONFERENCE (2023) (0)
- The role of percentage of PSA reduction after focal therapy using high intensity focused ultrasound for primary localized prostate cancer. Results from a large multinstitutional series (2020) (0)
- MP23-20 LOW PSA DENSITY AT BASELINE IS ASSOCIATED WITH PROLONGED MRI-BASED ACTIVE SURVEILLANCE FOR GLEASON 6 PROSTATE CANCER (2020) (0)
- PD50-07 TIME TRENDS AND GEOGRAPHIC VARIABILITY IN PREOPERATIVE MRI FOR PROSTATE CANCER AND ITS ASSOCIATION WITH SURGICAL MARGIN STATUS IN THE UNITED STATES (2021) (0)
- Minimally Invasive Technologies in the Treatment of Renal and Prostate Cancer (2010) (0)
- Factors Influencing Variability in the Performance of mp-MRI in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review (2020) (0)
- MP78-05 MEDIUM TERM ONCOLOGICAL OUTCOMES IN A LARGE COHORT OF MEN TREATED WITH EITHER FOCAL- OR HEMI-ABALTION WITH HIFU FOR PRIMARY LOCALIZED PROSTATE CANCER (2019) (0)
- MP77-20 PREDICTION OF SIGNIFICANT PROSTATE CANCER IN BIOPSY-NAÏVE MEN: EXTERNAL VALIDATION OF A NOVEL RISK MODEL COMBINING MRI AND CLINICAL PARAMETERS (2018) (0)
- Let's Follow the Golden Mean: Using Magnetic Resonance Imaging to Determine the Need for Biopsy in Men on Active Surveillance. (2020) (0)
- MP64-15 GLOBAL VARIATIONS IN TREATMENT DECISIONS AMONG MEN WITH LOCALIZED PROSTATE CANCER: PATTERNS OF CARE IN 15,718 MEN FROM 9 COUNTRIES (2020) (0)
- Global variation in the quality of multiparametric magnetic resonance imaging of the prostate from the PRIMEtrial (the glimpse study) (2023) (0)
- Pathologic findings and MRI concordance at salvage radical prostatectomy for local recurrence following partial ablation using high-intensity focused ultrasound (2019) (0)
- POD-07.06 Inter-observer Variability in the Interpretation of HistoScanning™ Characterisation of Prostate Cancer (2011) (0)
- MP05-14 THE DIAGNOSTIC PATHWAY OF PROSTATE CANCER IN THE MRI ERA INCLUDING RISK STRATIFICATION: APPLYING THE ROTTERDAM PROSTATE CANCER RISK CALCULATOR TO THE PRECISION TRIAL DATA (2021) (0)
- Focal Therapy Using High Intensity Focused Ultrasound for Intermediate and High Risk Prostate Cancer: A Registry-Based Cohort Analysis (2010) (0)
- The Role of mp-MRI in the Detection of Prostate Cancer (2012) (0)
- B2B: Prostate Cancer (2021) (0)
- Multiparametric MRI in the diagnosis of prostate cancer: a validation study of the European Consensus Meeting Risk Scoring System (2013) (0)
- Photodynamic Therapy for Early Prostate Cancer (2013) (0)
- Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy? (2022) (0)
- Time to evaluate focal therapy (2010) (0)
- Corrigendum to "Magnetic Resonance Imaging and targeted biopsies compared to transperineal mapping biopsies prior to salvage focal therapy/ablation in localised and metastatic recurrent prostate cancer after radiotherapy. Primary Outcomes from the FORECAST Trial" [Eur Urol 2022;81(6):598-605]. (2023) (0)
- The role of MRI and PET/CT in the primary staging of newly diagnosed prostate cancer: a systematic review of the literature (2021) (0)
- Photodynamic therapy for prostate cancer - A novel technique for assessing light transmission in the prostate (2004) (0)
- Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur (2019) (0)
- 353 Report from an international consensus meeting on focal therapy (2014) (0)
- 138 Standards in reporting of MRI-targeted prostate biopsies (START): Recommendations from an international working party (2013) (0)
- Re : Prostate-Specific Antigen Decline after 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer (2016) (0)
- MP40-14 IS LOCAL ANAESTHETIC TRANSPERINEAL PROSTATE BIOPSY FEASIBLE AND ACCEPTABLE? A COMPARISON OF PATIENT EXPERIENCE UNDER LOCAL ANESTHETIC (LA) OR SEDATION. (2018) (0)
- A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre. (2023) (0)
- Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning (2018) (0)
- MP-03.10 Can Pre-biopsy Multi-parametric MRI Reduce the Number of TRUS Cores Required to Diagnose Prostate Cancer in an 'At-Risk' Population of Men? (2011) (0)
- 218 Association of level of suspicion of prostate cancer on multi-parametric MRI with detection rate of prostate cancer (2013) (0)
- Functional outcomes from the Robotic surgery After Focal Therapy (RAFT) clinical trial (2020) (0)
- Re-Classification Strategies in Men with Low Risk Prostate Cancer: TRUS Guided Biopsy versus Template Prostate Mapping (2010) (0)
- MP30-10 HIFU DOSE ESCALATION LEADS TO FEWER RECURRENCES IN FOLLOWING FOCAL HIFU IN PROSTATE CANCER (2018) (0)
- Collaborative Quantization Embeddings for Intra-Subject Prostate MR Image Registration (2022) (0)
- 533 PERFORMANCE CHARACTERISTICS OF DIFFERENT TRANSRECTAL (TRB) AND TRANSPERINEAL MAPPING PROSTATE BIOPSY (TPB) STRATEGIES: A SIMULATION ON 96 CYSTOPROSTATECTOMY SPECIMENS (CPTS) (2011) (0)
- MRI in active surveillance: a critical review (2018) (0)
- 712 MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MP-MRI) AND LOCALISATION OF SIGNIFICANT PROSTATE CANCER: CAN IT BE USED AS A TRIAGE TOOL? (2010) (0)
- MP-21.13: Accuracy of Multi-sequence Magnetic Resonance Imaging of Radio-recurrent Prostate Cancer (2009) (0)
- Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7. (2020) (0)
- MP74-09 MRI PRO: A GLOBAL ONLINE SOLUTION FOR CASE-BASED TRAINING IN PROSTATE MRI - THE INITIAL LEARNER ANALYSIS (2019) (0)
- 267 Radiological progression in men with prostate cancer on active surveillance (2013) (0)
- START: The Beginning of a Multidisciplinary Effort to Define the Role of MRI-targeted Biopsy in the Detection of Clinically Significant Prostate Cancer (2013) (0)
- Transrectal ultrasound guided biopsy: effect on natural history of multi-parametric MRI signal and derived quantitative parameters (2014) (0)
- Diana L. Gallagher Introduction (2011) (0)
- The relationship between percentage PSA reduction and rate of failure after focal therapy for prostate cancer (2020) (0)
- A picture is worth a thousand words… but does it add utility to a nomogram to predict extraprostatic extension? (2018) (0)
- PD38-08 TRUENTH UK POST SURGERY – URINARY FUNCTION IN THE 1ST POST-OPERATIVE YEAR IN A 1000 MAN CONTEMPORARY RADICAL PROSTATECTOMY COHORT (2018) (0)
- Energies for Focal Ablation: Photodynamic Therapy (2011) (0)
- MP80-17 RACIAL DIFFERENCES IN PATIENT-REPORTED OUTCOMES AMONG MEN TREATED WITH RADICAL PROSTATECTOMY FOR PROSTATE CANCER (2023) (0)
- 104 WHO OPENED THE PROSTATE CANCER PANDORA'S BOX? A HISTORICAL EVALUATION OF THE DIAGNOSTIC PATHWAY IN PROSTATE CANCER (2011) (0)
- A first step towards a global nomogram to predict disease progression for men on active surveillance (2020) (0)
- Evaluation of Outcomes following Focal Ablative Therapy for Treatment of Localised Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-year Experience. (2023) (0)
- 528 RE-CLASSIFICATION STRATEGIES IN MEN WITH LOW RISK PROSTATE CANCER: TRUS GUIDED BIOPSY VERSUS TEMPLATE PROSTATE MAPPING (2011) (0)
- A BS TR AC T MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (2018) (0)
- 156 MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING IN RADIO-RECURRENT PROSTATE CANCER (2010) (0)
- Interobserver reproducibility of the Prostate Imaging Quality (PI-QUAL) score for prostate MRI quality (2021) (0)
- Role of age in a MRI-based active surveillance cohort: Association with clinical and radiological progression (2020) (0)
- Cancer control outcomes following focal therapy using HIFU in 1,829 men with non-metastatic prostate cancer treated over 15 years (2021) (0)
- 1215 THE ABILITY OF MRI GUIDED BIOPSY TO DETECT CLINICALLY SIGNIFICANT PROSTATE CANCER: A SYSTEMATIC REVIEW (2012) (0)
- 841 Medium term outcomes following focal HIFU for the treatment of non-metastatic prostate cancer: A UK registry analysis of 625 cases (2016) (0)
- PO-1752 Daily prostate ADC in patients having SABR and conventional prostate cancer treatment on an MR-Linac (2022) (0)
- 821 Magnetic resonance image-guided prostate biopsy versus transperineal template prostate biopsy in the diagnosis of clinically significant prostate cancer (2012) (0)
- Prostate Cancer Outcomes Global Initiative to Compare and Reduce Variation project: Understanding capacity of 25 international prostate cancer centres to collect a prostate cancer minimum dataset (2016) (0)
- PD50-05 VISIBLE DISEASE AT BASELINE ACCELERATES TIME TO EXIT FROM MRI-BASED ACTIVE SURVEILLANCE (2019) (0)
- 819 Does dutasteride make MRI visible lesions less conspicuous in men on active surveillance for prostate cancer? A pilot randomised controlled trial (2015) (0)
- Active Surveillance in 2020: A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for Active Surveillance (2020) (0)
- Improving the surgical treatment of high‐risk localised or locally advanced prostate cancer (2015) (0)
- MRI-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis (2019) (0)
- Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate Lesions. (2023) (0)
- Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis (2020) (0)
- MP38-10 MULTI-INSTITUTIONAL VALIDATION OF THE PRECISE CRITERIA ON PROSTATE MRI DURING ACTIVE SURVEILLANCE (2023) (0)
- 2581 Potential reduction of over treatment of localized prostate cancer using a cell cycle gene expression assay (Prolaris) in biopsy specimens: Results from the European multi-center EMPATHY-P study (2015) (0)
- Performance Characteristics of Prostate Biopsy Strategies in a Simulation: Transrectal Ultrasound (TRUS) versus Template Prostate Mapping (TPB) (2010) (0)
- Development and external validation of a novel model to identify patients with equivocal lesion at multiparametric MRI who can avoid prostate biopsy (2019) (0)
- Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype (2020) (0)
- Prostate cancer progression in Afro-Caribbean men: Should we be using the same active surveillance protocols as Caucasian men? (2020) (0)
- Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype (2020) (0)
- The need for advanced analytical methods for big data in urology: A first application from the ReIMAGINE risk study (2023) (0)
- Two Recent Tolkien Biographies (2002) (0)
- Inclusion: An Annotated Bibliography. 1995 Supplements. (1995) (0)
- Inclusion: An Annotated Bibliography. Supplement. (1994) (0)
- Editorial Comment. (2018) (0)
- Editorial Comment. (2021) (0)
- The Third Annual Learning Resources Conference Proceedings. (1976) (0)
- Editorial Comment. (2019) (0)
- MRI and targeted biopsies compared to transperineal mapping biopsies for targeted ablation in recurrent prostate cancer after radiotherapy: Primary outcomes of the FORECAST trial (2021) (0)
This paper list is powered by the following services:
Other Resources About Caroline Moore
What Schools Are Affiliated With Caroline Moore ?
Caroline Moore is affiliated with the following schools:
